|
|
Volumn 1, Issue 3, 2006, Pages 185-192
|
|
Nelarabine: a new purine analog in the treatment of hematologic malignancies.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
9 ARABINOFURANOSYLGUANINE;
9-ARABINOFURANOSYLGUANINE;
ARABINONUCLEOSIDE;
DRUG DERIVATIVE;
FLUDARABINE;
NELARABINE;
VIDARABINE;
BLOOD DISEASE;
CLINICAL TRIAL;
DNA REPAIR;
DOSE RESPONSE;
DRUG COMBINATION;
DRUG EFFECT;
DRUG RESISTANCE;
HUMAN;
LYMPHATIC LEUKEMIA;
METABOLISM;
PHOSPHORYLATION;
REVIEW;
T CELL LEUKEMIA LYMPHOMA;
TREATMENT OUTCOME;
ARABINONUCLEOSIDES;
CLINICAL TRIALS AS TOPIC;
DNA REPAIR;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG RESISTANCE;
DRUG THERAPY, COMBINATION;
HEMATOLOGIC NEOPLASMS;
HUMANS;
LEUKEMIA-LYMPHOMA, ADULT T-CELL;
PHOSPHORYLATION;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
TREATMENT OUTCOME;
VIDARABINE;
|
|
EID: 44849122586
PISSN: 15748871
EISSN: None
Source Type: Journal
DOI: 10.2174/157488706778250104 Document Type: Review |
|
Times cited : (7)
|
|
References (47)
|
